DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nexavar (Sorafenib) - News

 
 



News related to Nexavar (Sorafenib) and/or conditions it is approved for

OncoBriefs: Notable Studies from AACR
Source: MedPage Today Oncology/Hematology [2014.04.14]
SAN DIEGO (MedPage Today) -- Irregular menstrual cycles predicted an increased risk of ovarian cancer and dying of the disease, according to a study reported at the American Association for Cancer Research. Other meeting highlights included treatment advances in renal cell carcinoma, bladder cancer, and melanoma.

OncoBriefs: Notable Studies from AACR (CME/CE)
Source: MedPage Today Oncology/Hematology [2014.04.14]
SAN DIEGO (MedPage Today) -- Irregular menstrual cycles predicted an increased risk of ovarian cancer and dying of the disease, according to a study reported at the American Association for Cancer Research. Other meeting highlights included treatment advances in renal cell carcinoma, bladder cancer, and melanoma.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012